Android Apple

Here's What Analysts Are Forecasting For Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) After Its Second-Quarter Results

By Yahoo! Finance   |   4 months ago
Here's What Analysts Are Forecasting For Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) After Its Second-Quarter Results

Agios Pharmaceuticals reported weaker-than-expected quarterly results, with revenue missing predictions. Analysts forecast a revenue increase in 2024, with a projected profit of US$2.03 per share. Despite lower revenue estimates, earnings per share are expected to rise.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.